Jordan RoseFigura, PhD
Director of Material Sciences
In this webinar, you will discover:
- An overview of Swift Normalase™ Amplicon SARS-CoV-2 Panel (SNAP);
- Detailed information about the SNAP workflow, sophisticated primer design, and data analysis workflow;
- How overlapping primers in SNAP identify known and emerging SARS-CoV-2 variants;
- How targeted pathogen sequencing can enable variant detection in S Gene dropouts in COVID-19 samples.
In this webinar, Dr. Jordan RoseFigura provides an overview of targeted sequencing with Swift Biosciences™ Swift Normalase Amplicon SARS-CoV-2 Panel (SNAP) technology. The presentation will expand on the technology created to enable this research, which encompasses 99.7% of the SARS-CoV-2 genome from limited viral titers. It will include an overview of the elegant SNAP workflow, sophisticated primer design, data analysis workflow, as well as, how targeted pathogen sequencing can enable variant detection in S Gene dropouts in COVID-19 samples. Learn how adding Swift Normalase can save costs and time in order to scale large studies.
For research use only. Not for use in diagnostic procedures. Unless otherwise agreed to in writing, IDT does not intend these products to be used in clinical applications and does not warrant their fitness or suitability for any clinical diagnostic use. Purchaser is solely responsible for all decisions regarding the use of these products and any associated regulatory or legal obligations.